Document is current
Any future updates will be listed below
-
Authors
Callbo, Paliz Nordlöf https://orcid.org/0000-0002-4308-3745
Junus, Katja
Lindberger, Emelie
Lindström, Linda
Poromaa, Inger Sundström
Bergman, Lina
Lager, Susanne
Wikström, Anna-Karin
-
Funding
Funding for this research was provided by:
Uppsala University
- License Information
-
More Information
Article History
Received: 24 March 2026
Accepted: 2 July 2026
First Online: 6 July 2026
Declarations
:
: AKW and LB: Board members and responsible for the biobank in the IMPACT study, in which PlGF reagents were donated by Roche, Perkin Elmer, and Thermo Fischer. LB: Course leader for the course in Preeclampsia in Sweden with sponsorship by Thermo Fischer and Roche. Obtained reimbursement for lecture by iLab Medical and reimbursement from Homburg and Partner as expert opinion. Board member in intervention trials in which the trial drug has been donated by Merck. Expert opinion at DiaMedica.The remaining authors have no competing interests to declare that are relevant to the content of this article.
: The procedures of this study included written informed consent from participating women and ethics approval from the Regional Ethical Review Board in Uppsala, Sweden (Dnr: 2007/181, Dnr: 2018/251). All research was performed in accordance with relevant national and international guidelines.
